Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 17/20 | 0.61 |
| ▸ | NPY1R | P25929 | 10/20 | 0.61 |
| ▸ | NPY5R | Q15761 | 9/20 | 0.61 |
| ▸ | NPY2R | P49146 | 6/20 | 0.61 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29967116 | 0.94 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29991238 | 0.91 | NPY4R (0.53) | NPY4RNPY1RNPY5RNPY2RNPBWR1 | |
| SCHEMBL24049263 | 0.90 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL25867984 | 0.90 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL6471682 | 0.89 | NPY4R (0.58) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29569365 | 0.89 | NPY4R (0.49) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL31369288 | 0.88 | NPY4R (0.62) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29637607 | 0.88 | NPY4R (0.48) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30758138 | 0.87 | NPY4R (0.45) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30819414 | 0.87 | GNAI3 (0.46) | NPY4RNPY1RNPY5RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250230218-A1 | PDL1 PEPTIDES FOR USE IN CANCER VACCINES | IO BIOTECH APS (DK) | 2025-07-17 | — | — | US | disclosed |
| US-12187782-B2 | PDL1 peptides for use in cancer vaccines | IO BIOTECH APS (DK) | 2025-01-07 | — | — | US | disclosed |
| US-20220372108-A1 | PDL1 PEPTIDES FOR USE IN CANCER VACCINES | IO BIOTECH APS (DK) | 2022-11-24 | — | — | US | disclosed |